Study Evaluating INS018_055 Administered Orally to Subjects With Idiopathic Pulmonary Fibrosis (IPF)
Clinical trial NCT05938920 · COMPLETED
Trial details
- NCT number
- NCT05938920
- Sponsor
- InSilico Medicine Hong Kong Limited
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-06-19
- Primary completion
- 2024-08-08
- Enrollment
- 71
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.